The DNDi Board of Directors is made up of seven to thirteen members. In principle, board members serve for a term of four years, for a maximum of three consecutive terms. The board members include a patient advocate, to represent the affected communities we serve and to demonstrate the key role of the patient at the centre of the organization, and a nominate from each of the six Founding Partners. The Board of Directors is then free to appoint additional board members that fill skill areas not represented by the board members appointed by the Founding Partners or the patient advocate. A representative of the World Health Organisation as represented by UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) and the Chair of the DNDi Scientific Advisory Committee are permanent observers. The DNDi Executive Director is a permanent invitee. The Board of Directors elects the Chair, the Secretary, and the Treasurer among its members. Our regional entities are governed by regional Boards of Directors.

The Board of Directors highly values diversity within DNDi and is committed to encourage inclusion, in all its forms. It is committed to improving the diversity in board membership when appropriate opportunities arise. When a new board member is sought, all aspects of diversity, including, but not limited to, gender diversity, are considered, in addition to other criteria of skills, knowledge, and experience. For example, the Board strives to ensure that the candidate pool for each new appointment includes a mixture of both male and female candidates.

 

Marie-Paule Kieny, Chair
Institut national de la santé et de la recherche médicale (INSERM), France

Suerie MoonSecretary
Harvard University, United States

Frédéric Vallat, Treasurer
Ville de Genève, Switzerland

Noor Hisham Abdullah
Ministry of Health, Malaysia

Balram Bhargava
Indian Council of Medical Research (ICMR) and Ministry of Health & Family Welfare, India

Jorge Bermudez
Fundação Oswaldo Cruz, Brazil

Stewart Cole
Institut Pasteur, France

Paul Herrling

Paul Herrling
Formerly with Novartis International AG, Switzerland

Joanne Liu
Médecins Sans Frontières (MSF)

Bernhards Ogutu
Kenya Medical Research Institute (KEMRI), Kenya

Bennett Shapiro
PureTech Ventures, formerly with Merck & Co., USA

 


Nick White, Permanent Observer
Mahidol Oxford Tropical Medicine Research Unit